1. Molecular mechanisms in temozolomide-resistant glioblastoma
   Sang Y. Lee et al, 2021, Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies CrossRef
2. Differential regulation of the pro-inflammatory biomarker, YKL-40/CHI3L1, by PTEN/Phosphoinositide 3-kinase and JAK2/STAT3 pathways in glioblastoma
   Yubing Wang et al, 2018, Cancer Letters CrossRef
3. TrkB-containing exosomes promote the transfer of glioblastoma aggressiveness to YKL-40-inactivated glioblastoma cells
   Sandra Pinet et al, 2016, Oncotarget CrossRef
4. Influence of YKL‑40 gene RNA interference on the biological behaviors of endometrial cancer HEC‑1A cells
   Lili Li et al, 2018, Oncology Letters CrossRef
5. The E3 Ubiquitin Ligase NEDD4-1 Mediates Temozolomide-Resistant Glioblastoma through PTEN Attenuation and Redox Imbalance in Nrf2–HO-1 Axis
   Hao-Yu Chuang et al, 2021, International Journal of Molecular Sciences CrossRef
6. Functional analysis of the short splicing variant encoded by CHI3L1/YKL-40 in glioblastoma
   Mengqi Shi et al, 2022, Frontiers in Oncology CrossRef
7. CHI3L1 predicted in malignant entities is associated with glioblastoma immune microenvironment
   Fei Li et al, 2022, Clinical Immunology CrossRef
8. Knockdown of YKL‐40 inhibits angiogenesis through regulation of VEGF/VEGFR2 and ERK1/2 signaling in endometrial cancer
   Hong‐Yan Chen et al, 2021, Cell Biology International CrossRef
9. Bioactive triterpenoid saponins and phenolic compounds against glioma cells
   Xuewei Ye et al, 2014, Bioorganic & Medicinal Chemistry Letters CrossRef
10. Hi-LASSO: High-Dimensional LASSO
    Youngsoon Kim et al, 2019, IEEE Access CrossRef
11. MAPK8 mediates resistance to temozolomide and apoptosis of glioblastoma cells through MAPK signaling pathway
    Peng Xu et al, 2018, Biomedicine & Pharmacotherapy CrossRef
12. High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder
    Ying-En Lee et al, 2019, Urologic Oncology: Seminars and Original Investigations CrossRef
13. CHI3L1, NTRK2, 1p/19q and IDH Status Predicts Prognosis in Glioma
    Elise Deluche et al, 2019, Cancers CrossRef
14. Mesenchymal/radioresistant traits in granular astrocytomas: evidence from a combined clinical and molecular approach
    Rebecca Senetta et al, 2016, Histopathology CrossRef
15. High VEGFA Expression Is Associated with Improved Progression-Free Survival after Bevacizumab Treatment in Recurrent Glioblastoma
    Bárbara Alves et al, 2023, Cancers CrossRef
16. The anti-tumor activity of the STAT3 inhibitor STX-0119 occurs via promotion of tumor-infiltrating lymphocyte accumulation in temozolomide-resistant glioblastoma cell line
    Yasuto Akiyama et al, 2017, Immunology Letters CrossRef
17. Chitinase-3 like-protein-1 function and its role in diseases
    Ting Zhao et al, 2020, Signal Transduction and Targeted Therapy CrossRef
18. The Evaluation of AREG, MMP-2, CHI3L1, GFAP, and OPN Serum Combined Value in Astrocytic Glioma Patients’ Diagnosis and Prognosis
    Rūta Urbanavičiūtė et al, 2020, Brain Sciences CrossRef
19. Role of chitinase-like proteins in cancer
    Julia Kzhyshkowska et al, 2016, Biological Chemistry CrossRef
20. Enhancing Transcriptional Reprogramming of Mesenchymal Glioblastoma with Grainyhead-like 2 and HDAC Inhibitors Leads to Apoptosis and Cell-Cycle Dysregulation
    Spandana Kotian et al, 2023, Genes CrossRef
21. Prognostic Value of YKL-40 in Patients with Glioblastoma: a Systematic Review and Meta-analysis
    Gang Qin et al, 2017, Molecular Neurobiology CrossRef
22. Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiforme
    Jennifer P. Newman et al, 2017, Nature Communications CrossRef
23. Targeted Therapy for Malignant Brain Tumors
    Paula Lam et al, 2016, Redox-Active Therapeutics CrossRef
24. Serum YKL-40 Level Positively Correlates With Uterine Leiomyomas
    Wenping Guo et al, 2016, Reproductive Sciences CrossRef
25. Frequent variations in cancer-related genes may play prognostic role in treatment of patients with chronic myeloid leukemia
    Alexander V. Lavrov et al, 2016, BMC Genetics CrossRef